Mavacamten Outcomes in Hypertrophic Cardiomyopathy (HCM) and the Associated Patient and Physician Experiences in the US

Recruiting

Trial locations(1 site)

United Kingdom

Adelphi Real World, Bollington, Macclesfield

Sponsor

Bristol-Myers Squibb

Enrollment target

~362 participants

Started

January 2026

Primary completion

December 2026

Age range

18 Years and older

Last updated on clinicaltrials.gov in April 2026.

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com

Bristol-Myers Squibb